CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
REVENUES		$ 1,769	$ 1,336	$ 2,448	$ 3,028
COST OF REVENUES		(1,675)	(225)	(2,198)	(507)
GROSS PROFIT		94	1,111	250	2,521
RESEARCH AND DEVELOPMENT EXPENSES	[1]	(10,013)	(6,023)	(17,347)	(12,123)
Less - grants		2,194	1,329	3,503	2,457
RESEARCH AND DEVELOPMENT EXPENSES, NET		(7,819)	(4,694)	(13,844)	(9,666)
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES	[1]	(2,206)	(2,001)	(4,201)	(3,823)
OPERATING LOSS		(9,931)	(5,584)	(17,795)	(10,968)
FINANCIAL EXPENSES		(901)	(642)	(1,805)	(1,799)
FINANCIAL INCOME		96	43	338	71
FINANCIAL EXPENSES - NET		(805)	(599)	(1,467)	(1,728)
LOSS FROM CONTINUING OPERATIONS		(10,736)	(6,183)	(19,262)	(12,696)
(LOSS) INCOME FROM DISCONTINUED OPERATIONS		(117)	1,112	(189)	1,653
NET LOSS FOR THE PERIOD		$ (10,853)	$ (5,071)	$ (19,451)	$ (11,043)
NET LOSS PER SHARE OF COMMON STOCK - BASIC AND DILUTED:
Loss from continuing operations (in dollars per share)		$ (0.11)	$ (0.06)	$ (0.2)	$ (0.14)
Income from discontinued operations (in dollars per share)		0	0.01	0	0.02
Net loss per share of common stock (in dollars per share)		$ (0.11)	$ (0.05)	$ (0.2)	$ (0.12)
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING LOSS PER SHARE - BASIC AND DILUTED: (in shares)		99,758,511	93,635,213	99,737,348	93,418,666

[1] Includes share-based compensation